BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 17626520)

  • 1. Cardiac treatment in neuro-muscular diseases.
    Nigro G; Politano L; Passamano L; Palladino A; De Luca F; Nigro G; Comi LI
    Acta Myol; 2006 Dec; 25(3):119-23. PubMed ID: 17626520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiac management in neuromuscular diseases.
    Allen HD; Thrush PT; Hoffman TM; Flanigan KM; Mendell JR
    Phys Med Rehabil Clin N Am; 2012 Nov; 23(4):855-68. PubMed ID: 23137741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cardiomyopathy in hereditary muscular dystrophies].
    Hasselberg NE; Berge KE; Rasmussen M; Früh A; Ørstavik K; Haugaa KH
    Tidsskr Nor Laegeforen; 2018 Jan; 138(1):. PubMed ID: 29313627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac involvement in patients with limb-girdle muscular dystrophy type 2 and Becker muscular dystrophy.
    Sveen ML; Thune JJ; Køber L; Vissing J
    Arch Neurol; 2008 Sep; 65(9):1196-201. PubMed ID: 18779423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular magnetic resonance reveals similar damage to the heart of patients with Becker and limb-girdle muscular dystrophy but no cardiac symptoms.
    Yilmaz A; Gdynia HJ; Mahrholdt H; Sechtem U
    J Magn Reson Imaging; 2009 Oct; 30(4):876-7. PubMed ID: 19787739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progression of cardiac involvement in patients with limb-girdle type 2 and Becker muscular dystrophies: a 9-year follow-up study.
    Petri H; Sveen ML; Thune JJ; Vissing C; Dahlqvist JR; Witting N; Bundgaard H; Køber L; Vissing J
    Int J Cardiol; 2015 Mar; 182():403-11. PubMed ID: 25596466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outpatient continuous inotrope infusion as an adjunct to heart failure therapy in Duchenne muscular dystrophy.
    Cripe LH; Barber BJ; Spicer RL; Wong BL; Weidner N; Benson DW; Markham LW
    Neuromuscul Disord; 2006 Nov; 16(11):745-8. PubMed ID: 17005398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Learning disabilities in neuromuscular disorders: a springboard for adult life.
    Astrea G; Battini R; Lenzi S; Frosini S; Bonetti S; Moretti E; Perazza S; Santorelli FM; Pecini C
    Acta Myol; 2016 Oct; 35(2):90-95. PubMed ID: 28344438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hereditary muscular dystrophies and the heart.
    Hermans MC; Pinto YM; Merkies IS; de Die-Smulders CE; Crijns HJ; Faber CG
    Neuromuscul Disord; 2010 Aug; 20(8):479-92. PubMed ID: 20627570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac Intervention Improves Heart Disease and Clinical Outcomes in Patients With Muscular Dystrophy in a Multidisciplinary Care Setting.
    Nikhanj A; Yogasundaram H; Miskew Nichols B; Richman-Eisenstat J; Phan C; Bakal JA; Siddiqi ZA; Oudit GY
    J Am Heart Assoc; 2020 Jan; 9(2):e014004. PubMed ID: 31931688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiac involvement in myotonic dystrophy, Becker muscular dystrophy and mitochondrial myopathy: a five-year follow-up.
    Finsterer J; Stöllberger C; Blazek G; Spahits E
    Can J Cardiol; 2001 Oct; 17(10):1061-9. PubMed ID: 11694896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral health considerations in muscular dystrophies.
    Balasubramaniam R; Sollecito TP; Stoopler ET
    Spec Care Dentist; 2008; 28(6):243-53. PubMed ID: 19068065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurotrophins, cytokines, oxidative parameters and funcionality in Progressive Muscular Dystrophies.
    Comim CM; Mathia GB; Hoepers A; Tuon L; Kapczinski F; Dal-Pizzol F; Quevedo J; Rosa MI
    An Acad Bras Cienc; 2015 Sep; 87(3):1809-18. PubMed ID: 25910175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New approaches in the therapy of cardiomyopathy in muscular dystrophy.
    McNally EM
    Annu Rev Med; 2007; 58():75-88. PubMed ID: 17217326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiac involvement over 10 years in myotonic and Becker muscular dystrophy and mitochondrial disorder.
    Finsterer J; Stöllberger C; Blazek G; Kunafer M; Prager E
    Int J Cardiol; 2007 Jul; 119(2):176-84. PubMed ID: 17258336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensin-converting enzyme inhibitors and beta-blockers in cardiac asymptomatic patients with Duchenne muscular dystrophy.
    Fayssoil A
    Indian Heart J; 2010; 62(3):273. PubMed ID: 21275309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiac involvement in Becker's muscular dystrophy, necessitating heart transplantation, 6 years before apparent skeletal muscle involvement.
    Finsterer J; Bittner RE; Grimm M
    Neuromuscul Disord; 1999 Dec; 9(8):598-600. PubMed ID: 10619719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Left ventricular aneurysm in a patient with Duchenne muscular dystrophy.
    Fayssoil A; Abdallah C; Orlikowski D
    Presse Med; 2014 Jun; 43(6 Pt 1):731-2. PubMed ID: 24525307
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment of the heart in Duchenne muscular dystrophy.
    Baxter P
    Dev Med Child Neurol; 2006 Mar; 48(3):163. PubMed ID: 16483388
    [No Abstract]   [Full Text] [Related]  

  • 20. Cardiac monitoring and treatment for children and adolescents with neuromuscular disorders.
    English KM; Gibbs JL
    Dev Med Child Neurol; 2006 Mar; 48(3):231-5. PubMed ID: 16483403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.